Citations

Mayo Clinic

Showing 10 of 108523 citations.

The Clinical Determination of Brain Death: Rational and Reliable
Wijdicks, Eelco F. M.

Seminars in Neurology | April 3, 2015 | Volume: 35 | Issue: 02 | Pages: 103-104

10.1055/s-0035-1547531 | PMID 25839718 Get It

Neurological Aspects of Human Glycosylation Disorders
Freeze, Hudson H. , Eklund, Erik A. , Patterson, Marc C. , Ng, Bobby G. , Freeze, Hudson H , Patterson, Marc

Annual Review of Neuroscience | April 3, 2015 | Volume: 38 | Issue: 1 | Pages: 105-125

10.1146/annurev-neuro-071714-034019 | PMID 25840006 Get It

This review presents principles of glycosylation, describes the relevant glycosylation pathways and their related disorders, and highlights some of the neurological aspects and issues that continue to challenge researchers. More than 100 rare human genetic disorders that result from deficiencies in the different glycosylation pathways are known today. Most of these disorders impact the central and/or peripheral nervous systems. Patients typically have developmental delays/intellectual disabilities, hypotonia, seizures, neuropathy, and metabolic abnormalities in multiple organ systems. Among these disorders there is great clinical diversity because all cell types differentially glycosylate proteins and lipids. The patients have hundreds of misglycosylated products, which afflict a myriad of processes, including cell signaling, cell-cell interaction, and cell migration. This vast complexity in glycan composition and function, along with the limited availability of analytic tools, has impeded the identification of key glycosylated molecules that cause pathologies. To date, few critical target proteins have been pinpointed.
Brain Death Guidelines Explained
Wijdicks, Eelco F. M.

Seminars in Neurology | April 3, 2015 | Volume: 35 | Issue: 02 | Pages: 105-115

10.1055/s-0035-1547532 | PMID 25839719 Get It

Analysis of the Constraint Joint Loading in the Thumb During Pipetting
Wu, John Z. , Sinsel, Erik W. , Zhao, Kristin D. , An, Kai‐Nan , Buczek, Frank L., Trentadue, Taylor P

Journal of Biomechanical Engineering | April 3, 2015 | Volume: 137 | Issue: 8 | Pages: No page available

10.1115/1.4030311 | PMID 25839321 Get It

Dynamic loading on articular joints is essential for the evaluation of the risk of the articulation degeneration associated with occupational activities. In the current study, we analyzed the dynamic constraint loading for the thumb during pipetting. The constraint loading is considered as the loading that has to be carried by the connective tissues of the joints (i.e., the cartilage layer and the ligaments) to maintain the kinematic constraints of the system. The joint loadings are solved using a classic free-body approach, using the external loading and muscle forces, which were obtained in an inverse dynamic approach combined with an optimization procedure in anybody. The constraint forces in the thumb joint obtained in the current study are compared with those obtained in the pinch and grasp tests in a previous study (Cooney and Chao, 1977, “Biomechanical Analysis of Static Forces in the Thumb During Hand Function,” J. Bone Joint Surg. Am., 59(1), pp. 27–36). The maximal compression force during pipetting is approximately 83% and 60% greater than those obtained in the tip pinch and key pinch, respectively, while substantially smaller than that obtained during grasping. The maximal lateral shear force is approximately six times, 32 times, and 90% greater than those obtained in the tip pinch, key pinch, and grasp, respectively. The maximal dorsal shear force during pipetting is approximately 3.2 and 1.4 times greater than those obtained in the tip pinch and key pinch, respectively, while substantially smaller than that obtained during grasping. Our analysis indicated that the thumb joints are subjected to repetitive, intensive loading during pipetting, compared to other daily activities.
Biodegradable and crosslinkable PPF–PLGA–PEG self-assembled nanoparticles dual-decorated with folic acid ligands and Rhodamine B fluorescent probes for targeted cancer imaging
Liu, Xifeng , Yaszemski, Michael J. , Lu, Lichun , Miller, A. Lee , Miller, Alan Lee

RSC Advances | April 3, 2015 | Volume: 5 | Issue: 42 | Pages: 33275-33282

10.1039/c5ra04096e | PMID 35330847 Get It

Novel crosslinkable self-assembled PPF–PLGA–PEG nanoparticles with fluorescent RhB probes and FA ligands for targeted cancer imaging and potential drug delivery.
Intravitreal Aflibercept after Bilateral Bevacizumab‐Induced Iritis
Skorin, Leonid , Genereux, Lucas

Optometry and Vision Science | April 3, 2015 | Volume: 92 | Issue: 5 | Pages: No page available

10.1097/opx.0000000000000568 | PMID 25871873 Get It

ABSTRACT Purpose To present a case of neovascular age‐related macular degeneration treated with aflibercept intravitreal injections after bilateral bevacizumab injections, administered on separate dates, resulted in bilateral iritis. Case Report A 73‐year‐old woman with a previous history of two episodes of nongranulomatous iritis in her right eye that was believed to be associated with her systemic diagnosis of rheumatoid arthritis was treated with intravitreal bevacizumab injections for bilaterally occurring neovascular age‐related macular degeneration. Initial bevacizumab injections in each eye administered sequentially over a week's time resulted in immediate‐onset nongranulomatous iritis in each eye. Subsequent intravitreal injections of aflibercept were administered, and therapeutic benefit was achieved without occurrence of iritis. Conclusions In cases where intravitreal bevacizumab results in anterior uveitis, aflibercept may be a safe alternative therapeutic choice for the treatment of neovascular age‐related macular degeneration.
The Standardization Approach in End-of-Life Withdrawal of Life-Sustaining Treatment
Rady, Mohamed Y. , Verheijde, Joseph L.

Journal of Intensive Care Medicine | April 3, 2015 | Volume: 31 | Issue: 4 | Pages: 290-292

10.1177/0885066615578407 | PMID 25835021 Get It

Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci
Olama, Ali Amin Al , Benlloch, Sara, Antoniou, Antonis C. , Giles, Graham G. , Severi, Gianluca , Neal, David E. , Hamdy, Freddie C. , Donovan, Jenny , Muir, Kenneth , Schleutker, Johanna , Henderson, Brian E., Haiman, Christopher A. , Schumacher, Fredrick R. , Pashayan, Nora , Ostrander, Elaine A. , Stanford, Janet L. , Batra, Jyotsna , Clements, Judith A. , Chambers, Suzanne K. , Weischer, Maren , Nordestgaard, Børge G. , Sørensen, Karina D. , Ørntoft, Torben F., Maier, Christiane, Doerk, Thilo, Dickinson, Joanne L. , Cannon‐Albright, Lisa , Brenner, Hermann , Habuchi, Tomonori , Thibodeau, Stephen N. , Cooney, Kathleen A. , Chappuis, Pierre O. , Hutter, Pierre, Kaneva, Radka , Foulkes, William D. , Lu, Yong‐Jie , Zhang, Hongwei , Stephenson, Robert A., Cox, Angela , Southey, Melissa C. , FitzGerald, Liesel M. , Leongamornlert, Daniel , Saunders, Edward J. , Tymrakiewicz, Malgorzata, Guy, Michelle, Little, Sarah J., Govindasami, Koveela, Sawyer, Emma, Wilkinson, Rosemary, Herkommer, Kathleen , Hopper, John L. , Lophatonanon, Aritaya, Rinckleb, Antje E., Eeles, Rosalind A. , Easton, Douglas F. , Dörk, Thilo , Aitken, Joanne F. , Borre, Michael , Lose, Felicity , Srinivasan, Srilakshmi , Tilley, Wayne D. , Samaratunga, Hemamali , Goranova, Teodora , Catto, James W.F. , Pharoah, Paul D.P. , Ingles, Sue A. , Park, Jong Y. , Cybulski, Cezary , Rebbeck, Timothy R. , Zeigler-Johnson, Charnita M , Zeegers, Maurice Petrus , Spurdle, Amanda B. , Dadaev, Tokhir , Kote‐Jarai, Zsofia , Dwyer, Terry , Dörk, Thilo , Giles, Graham G , Foulkes, William D , Eeles, Rosalind A , Southey, Melissa C , Donovan, Jenny L , Muir, Kenneth , Schleutker, Johanna , Pashayan, Nora , Cannon-Albright, Lisa A , Brenner, Hermann , Cox, Angela , Samaratunga, Hemamali , Severi, Gianluca , Batra, Jyotsna , Clements, Judith

Cancer Epidemiology, Biomarkers & Prevention | April 3, 2015 | Volume: 24 | Issue: 7 | Pages: 1121-1129

10.1158/1055-9965.epi-14-0317 | PMID 25837820 Get It

Abstract Background: Genome-wide association studies have identified multiple genetic variants associated with prostate cancer risk which explain a substantial proportion of familial relative risk. These variants can be used to stratify individuals by their risk of prostate cancer. Methods: We genotyped 25 prostate cancer susceptibility loci in 40,414 individuals and derived a polygenic risk score (PRS). We estimated empirical odds ratios (OR) for prostate cancer associated with different risk strata defined by PRS and derived age-specific absolute risks of developing prostate cancer by PRS stratum and family history. Results: The prostate cancer risk for men in the top 1% of the PRS distribution was 30.6 (95% CI, 16.4–57.3) fold compared with men in the bottom 1%, and 4.2 (95% CI, 3.2–5.5) fold compared with the median risk. The absolute risk of prostate cancer by age of 85 years was 65.8% for a man with family history in the top 1% of the PRS distribution, compared with 3.7% for a man in the bottom 1%. The PRS was only weakly correlated with serum PSA level (correlation = 0.09). Conclusions: Risk profiling can identify men at substantially increased or reduced risk of prostate cancer. The effect size, measured by OR per unit PRS, was higher in men at younger ages and in men with family history of prostate cancer. Incorporating additional newly identified loci into a PRS should improve the predictive value of risk profiles. Impact: We demonstrate that the risk profiling based on SNPs can identify men at substantially increased or reduced risk that could have useful implications for targeted prevention and screening programs. Cancer Epidemiol Biomarkers Prev; 24(7); 1121–9. ©2015 AACR.
Smoldering multiple myeloma
Rajkumar, S. Vincent , Landgren, Ola , Mateos, María‐Victoria , Rajkumar, S Vincent , Landgren, C Ola

Blood | April 3, 2015 | Volume: 125 | Issue: 20 | Pages: 3069-3075

10.1182/blood-2014-09-568899 | PMID 25838344 Get It

Abstract Smoldering multiple myeloma (SMM) is an asymptomatic clonal plasma cell disorder. SMM is distinguished from monoclonal gammopathy of undetermined significance by a much higher risk of progression to multiple myeloma (MM). There have been major advances in the diagnosis, prognosis, and management of SMM in the last few years. These include a revised disease definition, identification of several new prognostic factors, a classification based on underlying cytogenetic changes, and new treatment options. Importantly, a subset of patients previously considered SMM is now reclassified as MM on the basis of biomarkers identifying patients with an ≥80% risk of progression within 2 years. SMM has assumed greater significance on the basis of recent trials showing that early therapy can be potentially beneficial to patients. As a result, there is a need to accurately diagnose and risk-stratify patients with SMM, including routine incorporation of modern imaging and laboratory techniques. In this review, we outline current concepts in diagnosis and risk stratification of SMM, and provide specific recommendations on the management of SMM.
Accuracy of thyroid nodule sonography for the detection of thyroid cancer in children: systematic review and meta‐analysis
Nofal, Alaa Al , Gionfriddo, Michael R. , Javed, Asma , Haydour, Qusay, Brito, Juan P. , Pittock, Siobhán T. , Murad, M. Hassan , Al Nofal, Alaa, Murad, Mohammad Hassan, Prokop, Larry J. , Murad, M Hassan , Al Nofal, Alaa , Brito, Juan P

Clinical Endocrinology | April 2, 2015 | Volume: 84 | Issue: 3 | Pages: 423-430

10.1111/cen.12786 | PMID 25845503 Get It

SummaryIntroductionThyroid ultrasound (US) is a widely used tool for evaluating thyroid nodules. Various US features have been suggested as predictors of thyroid cancer in children.ObjectiveTo conduct a systematic review and meta‐analysis to assess the diagnostic accuracy of different thyroid US features in detecting thyroid cancer in children.MethodsWe searched multiple online databases for cohort studies that enrolled paediatric patients with thyroid nodules (age <21 years) and evaluated the accuracy of 12 relevant ultrasound features. Diagnostic measures were pooled across studies using a random effects model.ResultsThe search strategy yielded 1199 citations, of which 12 studies met the predefined inclusion criteria (750 nodules). The prevalence of thyroid cancer was 27·2% (40·8% in patients with a history of radiation exposure and 23·2% in patients without a history of exposure to radiation). The most common cancer was papillary thyroid cancer (86·7%). The presence of internal calcifications and enlarged cervical lymph nodes were the US features with the highest likelihood ratio [4·46 (95% CI: 1·87–10·64) and 4·96 (95% CI: 2·01–12·24), respectively] for thyroid cancer. A cystic nodule was the feature with highest likelihood ratio for benign nodules [1·96 (95% CI: 0·87–4·43)].ConclusionThyroid US features are not highly accurate predictors of benign or malignant aetiology of thyroid nodules in children. Internal calcification may predict malignancy, and cystic appearance may suggest benign aetiology.